Table: Sawai Pharmaceutical -2017/18 group forecast(IFRS)
May 14 (Reuters) -
Sawai Pharmaceutical Co Ltd
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
Full Year to Full Year to
Mar 31, 2018 Mar 31, 2018
LATEST PREVIOUS
FORECAST FORECAST
Sales 168.00 168.80
Operating 22.20 23.70
PreTax 20.20 23.30
Net 14.00 12.80
EPS Basic 360.06 yen 343.59 yen
NOTE - Sawai Pharmaceutical Co Ltd.(Figures are reported based on international accounting rules (IFRS).)
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4555.T
Recent news on SAWAI group
See all newsTable: Sawai Group Holdings -Q1 group results (IFRS)
Table: Sawai Group Holdings -2025/26 group results (IFRS)
Brief: Silchester International Cuts Stake In Sawai Group Holdings To 5.82% From 6.83%, Regulatory Filing Shows
Table: Sawai Group Holdings -9-MTH group results (IFRS)
Table: Sawai Group Holdings 6-MTH group results (IFRS)